Bremelanotide (PT 141)

Bremelanotide (PT 141) is a novel treatment for hypoactive sexual desire disorder that works by activating melanocortin receptors in the brain. This medication has shown effectiveness in improving sexual desire and satisfaction, offering a unique approach to addressing sexual health concerns.

Key Benefits

Improves sexual desire and satisfaction
Works through central nervous system
Quick onset of action
Well-tolerated by most patients
May enhance sexual function
Supports healthy sexual response

Scientific References

Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: A Review

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239890/

Mechanism and Efficacy of Bremelanotide in Sexual Dysfunction

https://www.example.com/bremelanotide-mechanism

Clinical Trials of Bremelanotide in Treating Hypoactive Sexual Desire

https://www.example.com/bremelanotide-clinical